Merit Medical Systems Shares Outstanding 2010-2024 | MMSI

Merit Medical Systems shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Merit Medical Systems shares outstanding for the quarter ending September 30, 2024 were 0.060B, a 1.99% increase year-over-year.
  • Merit Medical Systems 2023 shares outstanding were 0.058B, a 1.19% increase from 2022.
  • Merit Medical Systems 2022 shares outstanding were 0.058B, a 0.54% increase from 2021.
  • Merit Medical Systems 2021 shares outstanding were 0.057B, a 3.47% increase from 2020.
Merit Medical Systems Annual Shares Outstanding
(Millions of Shares)
2023 58
2022 58
2021 57
2020 55
2019 56
2018 54
2017 50
2016 45
2015 45
2014 43
2013 43
2012 43
2011 40
2010 36
2009 36
Merit Medical Systems Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 60
2024-06-30 59
2024-03-31 59
2023-12-31 58
2023-09-30 58
2023-06-30 58
2023-03-31 58
2022-12-31 58
2022-09-30 58
2022-06-30 58
2022-03-31 58
2021-12-31 57
2021-09-30 58
2021-06-30 57
2021-03-31 57
2020-12-31 55
2020-09-30 56
2020-06-30 55
2020-03-31 55
2019-12-31 56
2019-09-30 55
2019-06-30 57
2019-03-31 56
2018-12-31 54
2018-09-30 55
2018-06-30 52
2018-03-31 52
2017-12-31 50
2017-09-30 52
2017-06-30 51
2017-03-31 46
2016-12-31 45
2016-09-30 45
2016-06-30 45
2016-03-31 45
2015-12-31 45
2015-09-30 45
2015-06-30 45
2015-03-31 44
2014-12-31 43
2014-09-30 43
2014-06-30 43
2014-03-31 43
2013-12-31 43
2013-09-30 43
2013-06-30 43
2013-03-31 43
2012-12-31 43
2012-09-30 43
2012-06-30 42
2012-03-31 42
2011-12-31 40
2011-09-30 43
2011-06-30 38
2011-03-31 36
2010-12-31 36
2010-09-30 35
2010-06-30 36
2010-03-31 36
2009-12-31 36
2009-09-30 36
2009-06-30 36
2009-03-31 36
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $5.972B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.233B 19.03
Becton Dickinson (BDX) United States $69.388B 18.80
Cardinal Health (CAH) United States $27.972B 15.17
West Pharmaceutical Services (WST) United States $23.854B 48.72
Cooper (COO) United States $20.668B 29.42
Labcorp (LH) United States $19.603B 16.25
Align Technology (ALGN) United States $16.786B 32.12
Henry Schein (HSIC) United States $8.871B 16.63
DENTSPLY SIRONA (XRAY) United States $4.861B 13.03
CONMED (CNMD) United States $2.337B 19.50
Patterson (PDCO) United States $1.938B 10.23
STAAR Surgical (STAA) United States $1.521B 56.11
Lifevantage (LFVN) United States $0.175B 23.23
Pro-Dex (PDEX) United States $0.140B 27.95